News & Articles

Discover the latest technologies and techniques that are revolutionizing immuno-oncology research

Four new ZEISS Axiocam models are introduced for light microscopy applications

The introduction of a digital alert system to monitor patients with sepsis has led to a reduction in deaths and hospital stays

International panel of pathologists drive progressive agenda on the role of pathology in transforming cancer diagnostics and improving patient care

Instrument is designed to reduce the number of parts requiring disinfection after use

Adakveo targets key molecule for the prevention of sickle cell pathology

Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago

Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection

Paragon Genomics announced the two products at the 2019 Association for Molecular Pathology (AMP)

Watch this webinar to find out how to automate your NGS workflow for cancer diagnostics and personalized medicine

Hitachi and the Centre Leon Berard Cancer Center to launch research into diagnosis and treatment

Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

New kit from PerkinElmer shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media

The CPO Assay from BD and Check-Points can detect the 5 most common carbapenemase genes in less than 2.5 hours

Next-generation sequencing discovery pools enable larger custom panels and low sample numbers to speed up discovery

The new solution supports injection of different viscosities and volumes without the need for system customization

ATCC aim to increase confidence in research with its new genome database

Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization

The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer